David M. Johnson - Jun 15, 2022 Form 4 Insider Report for Aura Biosciences, Inc. (AURA)

Role
Director
Signature
/s/ Julie Feder, Attorney-in-fact
Stock symbol
AURA
Transactions as of
Jun 15, 2022
Transactions value $
$0
Form type
4
Date filed
6/17/2022, 05:07 PM
Previous filing
Jun 14, 2022
Next filing
Dec 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AURA Common Stock 30K Jun 15, 2022 Direct
holding AURA Common Stock 140K Jun 15, 2022 By Velocity Capital Management F1
holding AURA Common Stock 10K Jun 15, 2022 By NEJ09 IRREVOCABLE TRUST F2
holding AURA Common Stock 10K Jun 15, 2022 By NEJ12 IRREVOCABLE TRUST F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AURA Stock Option (Right to Buy) Award $0 +16K $0.00 16K Jun 15, 2022 Common Stock 16K $13.72 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Velosity Capital Management LLC is an entity that the reporting person is the sole member of.
F2 The shares are held by the NEJ09 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.
F3 The shares are held by the NEJ12 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.
F4 This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 15, 2023 or (b) the next annual meeting of the Issuer's stockholders.